Mental Health Center, The Affiliated Hospital of North Sichuan Medical College, Sichuan, 637000, Nanchong, China.
Department of Psychiatry, The First Affiliated Hospital of Jinan University, No. 613 Huangpu Avenue West, Tianhe District, 510632, Guangzhou, China.
Eur J Med Res. 2022 Jun 11;27(1):90. doi: 10.1186/s40001-022-00706-y.
Obesity is very common in patients with schizophrenia. We aimed to evaluate the influencing factors of obesity in community patients with deficit schizophrenia, to provide implication for schizophrenia management in community.
We selected patients with deficit schizophrenia who lived in 10 communities in our city from March 1 to June 30, 2021. The characteristics of included schizophrenia patients were evaluated and analyzed. Pearson correlation analysis was conducted to evaluate the obesity and related characteristics. Logistic regression analyses were conducted to assess the risk factors of obesity in patients with schizophrenia.
A total of 284 patients with schizophrenia were included, the incidence of obesity in patients with schizophrenia was 56.70%. gender (r = 0.619), waist circumference (r = 0.644), BMI (r = 0.891), diabetes (r = 0.698), FG (r = 0.582), triglyceride (r = 0.618), HDL-C (r = -0.644), LDL-C (r = 0.583), apolipoprotein B (r = 0.595), and PANSS score (r = 0.813) were all correlated with the obesity in patients with schizophrenia (all p < 0.05). Logistic regression analysis indicated that female (OR 2.129, 95% CI 1.615-3.022), waist circumference ≥ 90 cm (OR 3.814, 95% CI 2.778 ~ 4.312), diabetes (OR 2.856, 95% CI 1.905 ~ 3.448), FG ≥ 88 mg/dL (OR 1.551, 95% CI 1.284 ~ 2.183), triglyceride ≥ 160 mg/dL (OR 1.804, 95% CI 1.236-2.845), HDL-C ≤ 0.8 mmol/L (OR 2.032, 95% CI 1.614-3.079), LDL-C ≥ 2.0 mmol/L (OR 1.926, 95% CI 1.442-2.041) and apolipoprotein B ≥ 0.70 g/L (OR 2.119, 95% CI 1.658-2.873) were the risk factors of obesity in patients with schizophrenia (all p < 0.05).
The obesity rate of patients with deficit schizophrenia in the community is high, and there are many associated risk factors. Early intervention targeted on those risk factors are warranted to reduce the obesity in schizophrenia patients.
精神分裂症患者中肥胖非常常见。本研究旨在评估社区中缺陷型精神分裂症患者肥胖的影响因素,为社区精神分裂症管理提供依据。
选取 2021 年 3 月 1 日至 6 月 30 日期间居住在我市 10 个社区的缺陷型精神分裂症患者,评估并分析纳入精神分裂症患者的特征。采用 Pearson 相关分析评估肥胖与相关特征的关系。采用 logistic 回归分析评估精神分裂症患者肥胖的危险因素。
共纳入 284 例精神分裂症患者,肥胖发生率为 56.70%。性别(r=0.619)、腰围(r=0.644)、BMI(r=0.891)、糖尿病(r=0.698)、空腹血糖(r=0.582)、三酰甘油(r=0.618)、高密度脂蛋白胆固醇(r=-0.644)、低密度脂蛋白胆固醇(r=0.583)、载脂蛋白 B(r=0.595)和阳性和阴性症状量表(PANSS)评分(r=0.813)与精神分裂症患者肥胖均相关(均 P<0.05)。logistic 回归分析表明,女性(OR=2.129,95%CI=1.6153.022)、腰围≥90cm(OR=3.814,95%CI=2.7784.312)、糖尿病(OR=2.856,95%CI=1.9053.448)、空腹血糖≥88mg/dL(OR=1.551,95%CI=1.2842.183)、三酰甘油≥160mg/dL(OR=1.804,95%CI=1.2362.845)、高密度脂蛋白胆固醇≤0.8mmol/L(OR=2.032,95%CI=1.6143.079)、低密度脂蛋白胆固醇≥2.0mmol/L(OR=1.926,95%CI=1.4422.041)和载脂蛋白 B≥0.70g/L(OR=2.119,95%CI=1.6582.873)是精神分裂症患者肥胖的危险因素(均 P<0.05)。
社区中缺陷型精神分裂症患者肥胖率较高,存在较多相关危险因素。针对这些危险因素进行早期干预,有望降低精神分裂症患者的肥胖率。